Title of article
NSAIDs and COVID-19: A New Challenging Area
Author/Authors
Baradaran, Hananeh Department of Clinical Pharmacy - Tehran University of Medical Sciences, Tehran, Iran , Hamishehkar, Hadi Department of Clinical Pharmacy - Tabriz University of Medical Sciences, Tabriz, Iran , Rezaee, Haleh Department of Clinical Pharmacy - Tabriz University of Medical Sciences, Tabriz, Iran
Pages
3
From page
49
To page
51
Abstract
Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence for the use of NSAIDs in viral respiratory tract infections to help make decisions in this area. Currently, there is insufficient
evidence to judge the safety and efficacy of NSAIDs in patients with COVID-19. According to the current evidence, acetaminophen is the choice treatment for symptomatic relief. If the patients’ symptoms are not controlled by acetaminophen, naproxen may be used as an alternative therapy.
Keywords
NSAIDs , COVID-19 , Patients
Journal title
Pharmaceutical Sciences
Serial Year
2020
Record number
2522265
Link To Document